Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Increase only if weight loss stalls or hunger returns
Notable findings include: In the SURMOUNT-1 trial of tirzepatide for the treatment of obesity, secondary findings showed improvements in the GLP-1 treatment group in systolic blood pressure (-7.2mm Hg), diastolic blood pressure (-4.8mm Hg), triglycerides (-24.8mg/dl), fasting insulin (-42.9mIU liter), and total cholesterol (-4.8mg/dl)
The MHRA-approved Summary of Product Characteristics (SmPC) acknowledges these effects, which contribute to the weight loss observed in many patients, even when prescribed primarily for diabetes management
Note on the responsible body The responsible body for data processing on this website is: Gall-Pharma GmbH Mag
Benefits Outweigh Temporary Fatigue Despite initial tiredness, GLP-1 medications provide significant benefits in managing blood sugar and supporting weight loss
Cost Considerations for Long-Term Use Brand-name semaglutide costs $969 to $1,349 monthly, making long-term use prohibitively expensive for many people without insurance coverage
US$ 29.02
US$ 23.84
US$ 26.95
US$ 29.52
US$ 21.37
US$ 22.11
US$ 20.57
US$ 23.77
US$ 28.90
